NS398 induces apoptosis in non-small cell lung cancer cells

Journal of Cancer Research and Clinical Oncology

Volumn 138, Issue 1, 2012, Pages 119-124

  Qiu, Rong ^a   Chen, Jian ^a   Sima, Jun ^b   Shen, Xiangdi ^a   Liu, Dandan ^a   Shen, Jian ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Red Cross Hospital in Hangzhou   (China)

Author keywords

Apoptosis; Caspase 3; Non small cell lung cancer; NS398; P AKT; Survivin

Indexed keywords

3 (4,5 DIMETHYL 2 THIAZOLYL) 2,5 DIPHENYLTETRAZOLIUM BROMIDE; CASPASE 3; MESSENGER RNA; N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE; PROTEIN KINASE B;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; ARTICLE; CANCER CELL; CANCER CELL DESTRUCTION; CANCER INHIBITION; CASPASE 3 GENE; CELL GROWTH; CELL PROLIFERATION; CELL STRUCTURE; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG EFFECT; DRUG MECHANISM; ENZYME PHOSPHORYLATION; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; LUNG NON SMALL CELL CANCER; NUCLEOTIDE SEQUENCE; ONCOGENE; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVIN GENE; WESTERN BLOTTING;

APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CASPASE 3; CELL GROWTH PROCESSES; CELL LINE, TUMOR; CYCLOOXYGENASE 2 INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; HUMANS; INHIBITOR OF APOPTOSIS PROTEINS; LUNG NEOPLASMS; NITROBENZENES; ONCOGENE PROTEIN V-AKT; PHOSPHORYLATION; SULFONAMIDES;

EID: 84857039455     PISSN: 01715216     EISSN: 14321335     Source Type: Journal    
DOI: 10.1007/s00432-011-1080-3     Document Type: Article

References (19)

1. Cappuzzo F, Magrini E, Ceresoli GL, Bartolini S, Rossi E, Ludovini V, Gregorc V, Ligorio C, Cancellieri A, Damiani S, Spreafico A, Paties CT, Lombardo L, Calandri C, Bellezza G, Tonato M, Crino L (2004) Akt phosphorylation and gefitinib efficacy in patients with advanced non-small-cell lung cancer. J Natl Cancer Inst 96:1133-1141 (Pubitemid 39207049)
2. Dahl C, Guldberg P (2007) The genome and epigenome of malignant melanoma. APMIS 115:1161-1176 (Pubitemid 350179478)
3. Dalwadi H, Krysan K, Heuze-Vourc'h N, Dohadwala M, Elashoff D, Sharma S, Cacalano N, Lichtenstein A, Dubinett S (2005). Cyclooxygenase-2-dependent activation of signal transducer and activator of transcription 3 by interleukin-6 in non-small cell lung cancer. Clin Cancer Res 11:7674-7682 (Pubitemid 41611609)
4. Fornaro M, Plescia J, Chheang S, Tallini G, Zhu YM, King M, Altieri DC, Languino LR (2003) Fibronectin protects prostate cancer cells from tumor necrosis factor-alpha-induced apoptosis via the AKT/survivin pathway. J Biol Chem 278:50402-50411 (Pubitemid 37548884)
5. Futaki N, Takahashi S, Yokoyama M, Arai I, Higuchi S, Otomo S (1994) NS-398, a new anti-inflammatory agent, selectively inhibits prostaglandin G/H synthase/cyclooxygenase (COX-2) activity in vitro. Prostaglandins 47:55-59 (Pubitemid 24053843)
6. Guo RH, Jin SD, Cai J, Huang ZH, Shu YQ (2008) Insulin/PI3K signalling pathway regulates the expression of survivin in liver cancer HepG2 cells. Zhonghua Zhong Liu Za Zhi 30:745-748
7. Guzinska-Ustymowicz K, Kemona A (2005) Transforming growth factor beta can be a parameter of aggressiveness of pT1 colorectal cancer. World J Gastroenterol 11:1193-1195 (Pubitemid 40353008)
8. Leng J, Han C, Demetris AJ, Michalopoulos GK, Wu T (2003) Cyclooxygenase-2 promotes hepatocellular carcinoma cell growth through Akt activation: evidence for Akt inhibition in celecoxib-induced apoptosis. Hepatology 38:756-768 (Pubitemid 37052162)
9. Miao LY, Wang J, Wu Q, Sun ZT, Wu YM, Wu YJ (2007) Expression of activated AKT, survivin and Bcl-2 in human nonsmall cell lung cancer. Tianjin Med J 35:241-243
10. Miyata Y, Koga S, Kanda S, Nishikido M, Hayashi T, Kanetake H (2003) Expression of cyclooxygenase-2 in renal cell carcinoma: correlation with tumor cell proliferation, apoptosis, angiogenesis, expression of matrix metalloproteinase-2, and survival. Clin Cancer Res 9:1741-1749 (Pubitemid 36554599)
11. Niu ZY, Cheng ZY, Liu YJ, Suo XH, Zhang XJ, Pan L (2010) Effect of integrin-mediated signal transduction pathways on apoptosis of K562 cells. Cancer Res Prev Treat 37:373-377
12. Peng XH, Karna P, Cao Z, Jiang BH, Zhou M, Yang L (2006) Crosstalk between epidermal growth factor receptor and hypoxiainducible factor-1alpha signal pathways increases resistance to apoptosis by up-regulating survivin gene expression. J Biol Chem 281:25903-25914 (Pubitemid 44401796)
13. Siezen CL, Tijhuis MJ, Kram NR, van Soest EM, de Jong DJ, Fodde R, van Kranen HJ, Kampman E (2006) Protective effect of nonsteroidal anti-inflammatory drugs on colorectal adenomas is modified by a polymorphism in peroxisome proliferator-activated receptor delta. Pharmacogenet Genomics 16:43-50 (Pubitemid 41803876)
14. Singhal S, Vachani A, Antin-Ozerkis D, Kaiser LR, Albelda SM (2005) Prognostic implications of cell cycle, apoptosis, and angiogenesis biomarkers in non-small cell lung cancer: a review. Clin Cancer Res 11:3974-3986 (Pubitemid 40791561)
15. Suzuki A, Ito T, Kawano H, Hayashida M, Hayasaki Y, Tsutomi Y, Akahane K, Nakano T, Miura M, Shiraki K (2000) Survivin initiates procaspase 3/p21 complex formation as a result of interaction with Cdk4 to resist Fas-mediated cell death. Oncogene 19:1346-1353 (Pubitemid 30160627)
16. Uddin S, Ahmed M, Hussain A, Assad L, Al-Dayel F, Bavi P, Al- Kuraya KS, Munkarah A (2010) Cyclooxygenase-2 inhibition inhibits PI3K/AKT kinase activity in epithelial ovarian cancer. Int J Cancer 126:382-394
17. Viniegra JG, Martinez N, Modirassari P, Losa JH, Parada CC, Lobo VJ, Luquero CI, Alvarez-Vallina L, Ramon YCS, Rojas JM, Sanchez-Prieto R (2005) Full activation of PKB/Akt in response to insulin or ionizing radiation is mediated through ATM. J Biol Chem 280:4029-4036 (Pubitemid 40288566)
18. Wang J, Yang L, Yang J, Kuropatwinski K, Wang W, Liu XQ, Hauser J, Brattain MG (2008) Transforming growth factor beta induces apoptosis through repressing the phosphoinositide 3-kinase/ AKT/survivin pathway in colon cancer cells. Cancer Res 68:3152-3160
19. Yamanaka Y, Shiraki K, Inoue T, Miyashita K, Fuke H, Yamaguchi Y, Yamamoto N, Ito K, Sugimoto K, Nakano T (2006) COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis. Int J Mol Med 18:41-47